Year |
Citation |
Score |
2020 |
Sato K, Padgaonkar A, Cosenza S, Baker S, Reddy R, Reddy EP, Irie HY. Abstract P5-05-04: A novel inhibitor of cancer stem cells overcomes chemotherapy resistance of triple negative breast cancers Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P5-05-04 |
0.718 |
|
2018 |
Padgaonkar A, Rechkoblit O, Vasquez-Del Carpio R, Pallela V, Venkata Subbaiah D, Cosenza SC, Baker SJ, Ramana Reddy MV, Aggarwal A, Reddy EP. Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemia. Oncotarget. 9: 37753-37765. PMID 30701029 DOI: 10.18632/Oncotarget.26514 |
0.758 |
|
2016 |
Perumal D, Kuo PY, Leshchenko VV, Jiang Z, Divakar SK, Cho HJ, Chari A, Brody J, Reddy MV, Zhang W, Reddy EP, Jagannath S, Parekh S. Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma. Cancer Research. PMID 26873845 DOI: 10.1158/0008-5472.Can-15-2934 |
0.325 |
|
2015 |
Reddy MV, Akula B, Jatiani S, Vasquez-Del Carpio R, Billa VK, Mallireddigari MR, Cosenza SC, Venkata Subbaiah DR, Bharathi EV, Pallela VR, Ramkumar P, Jain R, Aggarwal AK, Reddy EP. Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2). Bioorganic & Medicinal Chemistry. PMID 26762835 DOI: 10.1016/J.Bmc.2015.11.045 |
0.315 |
|
2014 |
Eachkoti R, Reddy MV, Lieu YK, Cosenza SC, Reddy EP. Identification and characterisation of a novel heat shock protein 90 inhibitor ONO4140. European Journal of Cancer (Oxford, England : 1990). 50: 1982-92. PMID 24835034 DOI: 10.1016/J.Ejca.2014.04.017 |
0.73 |
|
2014 |
Baker SJ, Ma'ayan A, Lieu YK, John P, Reddy MV, Chen EY, Duan Q, Snoeck HW, Reddy EP. B-myb is an essential regulator of hematopoietic stem cell and myeloid progenitor cell development. Proceedings of the National Academy of Sciences of the United States of America. 111: 3122-7. PMID 24516162 DOI: 10.1073/Pnas.1315464111 |
0.716 |
|
2014 |
Reddy MV, Akula B, Cosenza SC, Athuluridivakar S, Mallireddigari MR, Pallela VR, Billa VK, Subbaiah DR, Bharathi EV, Vasquez-Del Carpio R, Padgaonkar A, Baker SJ, Reddy EP. Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5). Journal of Medicinal Chemistry. 57: 578-99. PMID 24417566 DOI: 10.1021/Jm401073P |
0.731 |
|
2014 |
Perumal D, Leshchenko VV, Kuo P, Jiang Z, Readhead B, Eden C, Athaluri Divakar SK, Zhang W, Cho HJ, Chari A, Reddy M, Reddy EP, Dudley J, Jagannath S, Parekh S. Weighted Gene Co-Expression Network Analysis (WGCNA) Identifies Highly Proliferative Myeloma Subgroup Responsive to CDK4/ARK5 Inhibition Blood. 124: 3445-3445. DOI: 10.1182/Blood.V124.21.3445.3445 |
0.317 |
|
2013 |
Reddy MV, Mallireddigari MR, Pallela VR, Cosenza SC, Billa VK, Akula B, Subbaiah DR, Bharathi EV, Padgaonkar A, Lv H, Gallo JM, Reddy EP. Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents. Journal of Medicinal Chemistry. 56: 5562-86. PMID 23750455 DOI: 10.1021/Jm400575X |
0.729 |
|
2012 |
Baker SJ, Reddy EP. CDK4: A Key Player in the Cell Cycle, Development, and Cancer. Genes & Cancer. 3: 658-69. PMID 23634254 DOI: 10.1177/1947601913478972 |
0.306 |
|
2012 |
Lieu YK, Reddy EP. Impaired adult myeloid progenitor CMP and GMP cell function in conditional c-myb-knockout mice. Cell Cycle (Georgetown, Tex.). 11: 3504-12. PMID 22918254 DOI: 10.4161/cc.21802 |
0.724 |
|
2012 |
Reddy MV, Akula B, Cosenza SC, Lee CM, Mallireddigari MR, Pallela VR, Subbaiah DR, Udofa A, Reddy EP. (Z)-1-aryl-3-arylamino-2-propen-1-ones, highly active stimulators of tubulin polymerization: synthesis, structure-activity relationship (SAR), tubulin polymerization, and cell growth inhibition studies. Journal of Medicinal Chemistry. 55: 5174-87. PMID 22587519 DOI: 10.1021/Jm300176J |
0.371 |
|
2011 |
Reddy MV, Venkatapuram P, Mallireddigari MR, Pallela VR, Cosenza SC, Robell KA, Akula B, Hoffman BS, Reddy EP. Discovery of a clinical stage multi-kinase inhibitor sodium (E)-2-{2-methoxy-5-[(2',4',6'-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): synthesis, structure-activity relationship, and biological activity. Journal of Medicinal Chemistry. 54: 6254-76. PMID 21812421 DOI: 10.1021/Jm200570P |
0.399 |
|
2011 |
Oussenko IA, Holland JF, Reddy EP, Ohnuma T. Effect of ON 01910.Na, an anticancer mitotic inhibitor, on cell-cycle progression correlates with RanGAP1 hyperphosphorylation. Cancer Research. 71: 4968-76. PMID 21646468 DOI: 10.1158/0008-5472.Can-10-1603 |
0.366 |
|
2010 |
Samanta AK, Chakraborty SN, Wang Y, Schlette E, Reddy EP, Arlinghaus RB. Destabilization of Bcr-Abl/Jak2 Network by a Jak2/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML). Genes & Cancer. 1: 346-59. PMID 20798787 DOI: 10.1177/1947601910372232 |
0.407 |
|
2010 |
Chawla R, Procknow JA, Tantravahi RV, Khurana JS, Litvin J, Reddy EP. Cooperativity of Cdk4R24C and Ras in melanoma development. Cell Cycle (Georgetown, Tex.). 9: 3305-14. PMID 20703083 DOI: 10.4161/Cc.9.16.12632 |
0.58 |
|
2010 |
Reddy HK, Graña X, Dhanasekaran DN, Litvin J, Reddy EP. Requirement of Cdk4 for v-Ha-ras-Induced Breast Tumorigenesis and Activation of the v-ras-Induced Senescence Program by the R24C Mutation. Genes & Cancer. 1: 69-80. PMID 20634902 DOI: 10.1177/1947601909358105 |
0.315 |
|
2010 |
Abedin ZR, Ma Z, Reddy EP. Increased angiogenesis in Cdk4(R24C/R24C):Apc(+/Min) intestinal tumors. Cell Cycle (Georgetown, Tex.). 9: 2456-63. PMID 20603602 DOI: 10.4161/Cc.9.12.12055 |
0.74 |
|
2010 |
Baker SJ, Kumar A, Reddy EP. p89c-Myb is not required for fetal or adult hematopoiesis. Genesis (New York, N.Y. : 2000). 48: 309-16. PMID 20196078 DOI: 10.1002/Dvg.20619 |
0.485 |
|
2010 |
Reddy MV, Pallela VR, Cosenza SC, Mallireddigari MR, Patti R, Bonagura M, Truongcao M, Akula B, Jatiani SS, Reddy EP. Design, synthesis and evaluation of (E)-alpha-benzylthio chalcones as novel inhibitors of BCR-ABL kinase. Bioorganic & Medicinal Chemistry. 18: 2317-26. PMID 20188579 DOI: 10.1016/J.Bmc.2010.01.051 |
0.383 |
|
2010 |
Xu H, Dhanasekaran DN, Lee CM, Reddy EP. Regulation of neurite outgrowth by interactions between the scaffolding protein, JNK-associated leucine zipper protein, and neuronal growth-associated protein superior cervical ganglia clone 10. The Journal of Biological Chemistry. 285: 3548-53. PMID 19959466 DOI: 10.1074/Jbc.M109.064113 |
0.401 |
|
2010 |
Baek HJ, Pishvaian MJ, Cho KH, Mishra B, Reddy EP, Mishra L, Kim SS. Abstract LB-110: CDK4 activation is a key step in ELF alteration and haploinsufficeny ofcdk4prevents HCC formation inelf+/−mice Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-110 |
0.364 |
|
2010 |
Oussenko I, Holland JF, Reddy EP, Ohnuma T. Abstract 2500: ON 01910. Na, a clinical stage anticancer mitotic inhibitor, produces prolonged hyperphosphorylation of RanGAP1•SUMO1 as a potential mechanism of G2/M arrest and apoptosis Cancer Research. 70: 2500-2500. DOI: 10.1158/1538-7445.Am10-2500 |
0.367 |
|
2009 |
Lieu YK, Reddy EP. Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proceedings of the National Academy of Sciences of the United States of America. 106: 21689-94. PMID 19955420 DOI: 10.1073/Pnas.0907623106 |
0.721 |
|
2009 |
Ghosh SP, Perkins MW, Hieber K, Kulkarni S, Kao TC, Reddy EP, Reddy MV, Maniar M, Seed T, Kumar KS. Radiation protection by a new chemical entity, Ex-Rad: efficacy and mechanisms. Radiation Research. 171: 173-9. PMID 19267542 DOI: 10.1667/Rr1367.1 |
0.301 |
|
2009 |
Prasad A, Park IW, Allen H, Zhang X, Reddy MV, Boominathan R, Reddy EP, Groopman JE. Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells. Oncogene. 28: 1518-28. PMID 19198627 DOI: 10.1038/onc.2008.502 |
0.302 |
|
2009 |
Silverman LR, Odchimar-Reissig R, Navada SC, Ohnuma T, Najfeld V, Wilhelm F, Reddy EP, Holland JF. Effects of a Novel Benzyl Styryl Sulfone Derivative ON 01910.Na On the Myelodysplastic Syndrome (MDS) Derived Clone in Patients Relapsing Following Response to Azacitidine (AzaC) Therapy. Blood. 114: 4839-4839. DOI: 10.1182/Blood.V114.22.4839.4839 |
0.327 |
|
2009 |
Soper DM, Huang Y, Wilhelm F, Cosenza SC, Reddy EP, Cesano A, Greenberg PL, Fantl WJ. Single Cell Network Profiling (SCNP) to Evaluate the Mechanism of Action of ON 01910.Na, A Novel Clinical Trial Stage Compound. Blood. 114: 3827-3827. DOI: 10.1182/Blood.V114.22.3827.3827 |
0.39 |
|
2008 |
Reddy MV, Mallireddigari MR, Cosenza SC, Pallela VR, Iqbal NM, Robell KA, Kang AD, Reddy EP. Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents. Journal of Medicinal Chemistry. 51: 86-100. PMID 18088089 DOI: 10.1021/Jm701077B |
0.404 |
|
2007 |
Carbone CJ, Graña X, Reddy EP, Haines DS. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts. Cancer Research. 67: 4130-7. PMID 17483323 DOI: 10.1158/0008-5472.Can-07-0499 |
0.359 |
|
2007 |
Park IW, Reddy MV, Reddy EP, Groopman JE. Evaluation of novel cell cycle inhibitors in mantle cell lymphoma. Oncogene. 26: 5635-42. PMID 17369860 DOI: 10.1038/sj.onc.1210350 |
0.315 |
|
2006 |
Takaesu G, Kang JS, Bae GU, Yi MJ, Lee CM, Reddy EP, Krauss RS. Activation of p38alpha/beta MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein Cdo. The Journal of Cell Biology. 175: 383-8. PMID 17074887 DOI: 10.1083/Jcb.200608031 |
0.385 |
|
2006 |
Kashef K, Xu H, Reddy EP, Dhanasekaran DN. Endodermal differentiation of murine embryonic carcinoma cells by retinoic acid requires JLP, a JNK-scaffolding protein. Journal of Cellular Biochemistry. 98: 715-22. PMID 16619266 DOI: 10.1002/Jcb.20930 |
0.347 |
|
2006 |
Mangan JK, Tantravahi RV, Rane SG, Reddy EP. Granulocyte colony-stimulating factor-induced upregulation of Jak3 transcription during granulocytic differentiation is mediated by the cooperative action of Sp1 and Stat3. Oncogene. 25: 2489-99. PMID 16518416 DOI: 10.1038/Sj.Onc.1209280 |
0.624 |
|
2005 |
Reddy HK, Mettus RV, Rane SG, Graña X, Litvin J, Reddy EP. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis. Cancer Research. 65: 10174-8. PMID 16288002 DOI: 10.1158/0008-5472.Can-05-2639 |
0.374 |
|
2005 |
Kashef K, Lee CM, Ha JH, Reddy EP, Dhanasekaran DN. JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway. Biochemistry. 44: 14090-6. PMID 16245925 DOI: 10.1021/Bi050604L |
0.341 |
|
2005 |
Katuri V, Tang Y, Marshall B, Rashid A, Jogunoori W, Volpe EA, Sidawy AN, Evans S, Blay J, Gallicano GI, Reddy EP, Mishra L, Mishra B. Inactivation of ELF/TGF-β signaling in human gastrointestinal cancer Oncogene. 24: 8012-8024. PMID 16158060 DOI: 10.1038/Sj.Onc.1208946 |
0.35 |
|
2005 |
Nguyen Q, Lee CM, Le A, Reddy EP. JLP associates with kinesin light chain 1 through a novel leucine zipper-like domain. The Journal of Biological Chemistry. 280: 30185-91. PMID 15987681 DOI: 10.1074/Jbc.M505499200 |
0.479 |
|
2005 |
Tang Y, Katuri V, Srinivasan R, Fogt F, Redman R, Anand G, Said A, Fishbein T, Zasloff M, Reddy EP, Mishra B, Mishra L. Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. Cancer Research. 65: 4228-37. PMID 15899814 DOI: 10.1158/0008-5472.Can-04-4585 |
0.327 |
|
2005 |
Reddy NS, Gumireddy K, Mallireddigari MR, Cosenza SC, Venkatapuram P, Bell SC, Reddy EP, Reddy MV. Novel coumarin-3-(N-aryl)carboxamides arrest breast cancer cell growth by inhibiting ErbB-2 and ERK1. Bioorganic & Medicinal Chemistry. 13: 3141-7. PMID 15809149 DOI: 10.1016/J.Bmc.2005.02.051 |
0.45 |
|
2005 |
Gumireddy K, Reddy MV, Cosenza SC, Boominathan R, Boomi Nathan R, Baker SJ, Papathi N, Jiang J, Holland J, Reddy EP. ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell. 7: 275-86. PMID 15766665 DOI: 10.1016/J.Ccr.2005.02.009 |
0.333 |
|
2005 |
Gumireddy K, Baker SJ, Cosenza SC, John P, Kang AD, Robell KA, Reddy MV, Reddy EP. A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance. Proceedings of the National Academy of Sciences of the United States of America. 102: 1992-7. PMID 15677719 DOI: 10.1073/Pnas.0408283102 |
0.353 |
|
2005 |
Mangan JK, Reddy EP. Activation of the Jak3 pathway and myeloid differentiation. Leukemia & Lymphoma. 46: 21-7. PMID 15621777 DOI: 10.1080/10428190400005320 |
0.709 |
|
2004 |
Lieu YK, Kumar A, Pajerowski AG, Rogers TJ, Reddy EP. Requirement of c-myb in T cell development and in mature T cell function. Proceedings of the National Academy of Sciences of the United States of America. 101: 14853-8. PMID 15466706 DOI: 10.1073/Pnas.0405338101 |
0.723 |
|
2004 |
Mangan JK, Rane SG, Kang AD, Amanullah A, Wong BC, Reddy EP. Mechanisms associated with IL-6-induced up-regulation of Jak3 and its role in monocytic differentiation. Blood. 103: 4093-101. PMID 14976041 DOI: 10.1182/Blood-2003-06-2165 |
0.662 |
|
2003 |
Kumar A, Baker SJ, Lee CM, Reddy EP. Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb. Molecular and Cellular Biology. 23: 6631-45. PMID 12944488 DOI: 10.1128/Mcb.23.18.6631-6645.2003 |
0.54 |
|
2003 |
Kumar A, Lee CM, Reddy EP. c-Myc is essential but not sufficient for c-Myb-mediated block of granulocytic differentiation. The Journal of Biological Chemistry. 278: 11480-8. PMID 12525485 DOI: 10.1074/Jbc.M300080200 |
0.519 |
|
2002 |
Shore SK, Tantravahi RV, Reddy EP. Transforming pathways activated by the v-Abl tyrosine kinase. Oncogene. 21: 8568-76. PMID 12476303 DOI: 10.1038/Sj.Onc.1206084 |
0.382 |
|
2002 |
Lee CM, Onésime D, Reddy CD, Dhanasekaran N, Reddy EP. JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proceedings of the National Academy of Sciences of the United States of America. 99: 14189-94. PMID 12391307 DOI: 10.1073/Pnas.232310199 |
0.391 |
|
2002 |
Rane SG, Mangan JK, Amanullah A, Wong BC, Vora RK, Liebermann DA, Hoffman B, Graña X, Reddy EP. Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells. Blood. 100: 2753-62. PMID 12351382 DOI: 10.1182/Blood.V100.8.2753 |
0.705 |
|
2002 |
Rane SG, Reddy EP. JAKs, STATs and Src kinases in hematopoiesis. Oncogene. 21: 3334-58. PMID 12032773 DOI: 10.1038/Sj.Onc.1205398 |
0.405 |
|
2002 |
Rane SG, Cosenza SC, Mettus RV, Reddy EP. Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Molecular and Cellular Biology. 22: 644-56. PMID 11756559 DOI: 10.1128/Mcb.22.2.644-656.2002 |
0.365 |
|
2001 |
Kumar A, Reddy EP. Genomic organization and characterization of the promoter region of murine GSTM2 gene. Gene. 270: 221-9. PMID 11404019 DOI: 10.1016/S0378-1119(01)00473-5 |
0.46 |
|
2001 |
Baker SJ, Sumerson R, Reddy CD, Berrebi AS, Flynn DC, Reddy EP. Characterization of an alternatively spliced AATYK mRNA: expression pattern of AATYK in the brain and neuronal cells. Oncogene. 20: 1015-21. PMID 11314039 DOI: 10.1038/Sj.Onc.1204209 |
0.659 |
|
2001 |
Vora KA, Lentz VM, Monsell W, Rao SP, Mettus R, Toscani A, Reddy EP, Manser T. The T cell-dependent B cell immune response and germinal center reaction are intact in A-myb-deficient mice. Journal of Immunology (Baltimore, Md. : 1950). 166: 3226-30. PMID 11207276 DOI: 10.4049/Jimmunol.166.5.3226 |
0.35 |
|
2000 |
Reddy EP, Korapati A, Chaturvedi P, Rane S. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene. 19: 2532-47. PMID 10851052 DOI: 10.1038/Sj.Onc.1203594 |
0.746 |
|
2000 |
Baker SJ, Reddy EP. Cloning of murine G1RP, a novel gene related to Drosophila melanogaster g1. Gene. 248: 33-40. PMID 10806348 DOI: 10.1016/S0378-1119(00)00109-8 |
0.376 |
|
1999 |
Dermott JM, Reddy MR, Onesime D, Reddy EP, Dhanasekaran N. Oncogenic mutant of Galpha12 stimulates cell proliferation through cycloxygenase-2 signaling pathway. Oncogene. 18: 7185-9. PMID 10602471 DOI: 10.1038/Sj.Onc.1203345 |
0.331 |
|
1999 |
Oh IH, Reddy EP. The myb gene family in cell growth, differentiation and apoptosis. Oncogene. 18: 3017-33. PMID 10378697 DOI: 10.1038/Sj.Onc.1202839 |
0.396 |
|
1999 |
Lee CM, Reddy EP. The v-myc oncogene. Oncogene. 18: 2997-3003. PMID 10378695 DOI: 10.1038/Sj.Onc.1202786 |
0.364 |
|
1998 |
Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene. 17: 3261-70. PMID 9916988 DOI: 10.1038/Sj.Onc.1202568 |
0.315 |
|
1998 |
Garriga J, Limón A, Mayol X, Rane SG, Albrecht JH, Reddy EP, Andrés V, Graña X. Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation. The Biochemical Journal. 333: 645-54. PMID 9677324 DOI: 10.1042/Bj3330645 |
0.41 |
|
1998 |
Chaturvedi P, Reddy MV, Reddy EP. Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation. Oncogene. 16: 1749-58. PMID 9582023 DOI: 10.1038/Sj.Onc.1201972 |
0.415 |
|
1998 |
Oh IH, Reddy EP. The C-terminal domain of B-Myb acts as a positive regulator of transcription and modulates its biological functions. Molecular and Cellular Biology. 18: 499-511. PMID 9418897 DOI: 10.1128/Mcb.18.1.499 |
0.36 |
|
1997 |
Gaozza E, Baker SJ, Vora RK, Reddy EP. AATYK: a novel tyrosine kinase induced during growth arrest and apoptosis of myeloid cells. Oncogene. 15: 3127-35. PMID 9444961 DOI: 10.1038/sj.onc.1201575 |
0.313 |
|
1997 |
Suhasini M, Reddy CD, Reddy EP, DiDonato JA, Pilz RB. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation. Oncogene. 15: 1859-70. PMID 9362453 DOI: 10.1038/Sj.Onc.1201530 |
0.389 |
|
1997 |
Oh IH, Reddy EP. Murine A-myb gene encodes a transcription factor, which cooperates with Ets-2 and exhibits distinctive biochemical and biological activities from c-myb. The Journal of Biological Chemistry. 272: 21432-43. PMID 9261159 DOI: 10.1074/Jbc.272.34.21432 |
0.416 |
|
1996 |
Kumar A, Toscani A, Rane S, Reddy EP. Structural organization and chromosomal mapping of JAK3 locus. Oncogene. 13: 2009-14. PMID 8934548 |
0.365 |
|
1996 |
Leopold LH, Shore SK, Reddy EP. Multi-unit anti-BCR-ABL ribozyme therapy in chronic myelogenous leukemia. Leukemia & Lymphoma. 22: 365-73. PMID 8882949 DOI: 10.3109/10428199609054774 |
0.326 |
|
1996 |
Patel G, Tantravahi R, Oh IH, Reddy EP. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells. Oncogene. 13: 1197-208. PMID 8808694 |
0.338 |
|
1995 |
Grana X, Reddy EP. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs) Oncogene. 11: 211-219. PMID 7624138 |
0.306 |
|
1995 |
Lee KI, Reddy EP, Reddy CD. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter Journal of Biological Chemistry. 270: 24502-24508. PMID 7592667 DOI: 10.1074/Jbc.270.41.24502 |
0.327 |
|
1994 |
Inoue M, Koga Y, Djordjijevic D, Fukuma T, Reddy EP, Yokoyama MM, Sagawa K. Down-regulation of CD4 molecules by the expression of Nef: a quantitative analysis of CD4 antigens on the cell surfaces. International Immunology. 5: 1067-73. PMID 7902127 DOI: 10.1093/Intimm/5.9.1067 |
0.318 |
|
1994 |
Rane SG, Reddy EP. JAK3: A novel JAK kinase associated with terminal differentiation of hematopoietic cells Oncogene. 9: 2415-2423. PMID 7518579 |
0.324 |
|
Show low-probability matches. |